M A González-Gay Selected Research

M A González-Gay Research Topics

Disease

12	Rheumatoid Arthritis 10/2020 - 04/2000
5	Giant Cell Arteritis (Horton Disease) 01/2022 - 05/2000
5	Atherosclerosis 03/2014 - 01/2011
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2009 - 09/2005
4	Inflammation (Inflammations) 03/2014 - 09/2000
4	Cardiovascular Diseases (Cardiovascular Disease) 03/2014 - 04/2011
3	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 09/2015 - 05/2000
3	Ankylosing Spondylitis 03/2014 - 07/2004
3	Autoimmune Diseases (Autoimmune Disease) 09/2012 - 06/2006
2	Aortitis 03/2015 - 12/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2014 - 03/2014
2	Insulin Resistance 03/2014 - 06/2012
1	Vasculitis (Vasculitides) 09/2015
1	Pain (Aches) 03/2015
1	Neurosarcoidosis 03/2014
1	Sarcoidosis (Schaumann Disease) 03/2014
1	Infections 09/2013
1	Heart Diseases (Heart Disease) 10/2012
1	Fibrosis (Cirrhosis) 09/2012
1	Mononeuropathies (Mononeuritis Multiplex) 02/2002
1	Necrosis 02/2002
1	Hematuria 01/2001
1	Sjogren's Syndrome (Sjogren Syndrome) 11/2000
1	Anemia 09/2000
1	Stroke (Strokes) 05/2000
1	Diarrhea 03/2000
1	Synovitis 03/2000
1	Glomerulonephritis 01/2000

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 03/2014 - 09/2000
3	Infliximab (Remicade)FDA Link 03/2014 - 02/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2014 - 04/2000
2	EpitopesIBA 10/2012 - 04/2000
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 09/2012 - 12/2011
2	Interleukin-6 (Interleukin 6)IBA 09/2012 - 12/2011
2	HLA-DRB1 Chains (HLA DRB1)IBA 11/2000 - 04/2000
1	HomocysteineIBA 10/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2015
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2014
1	Interleukin-17 (Interleukin 17)IBA 09/2014
1	AdipokinesIBA 03/2014
1	Angiopoietin-2IBA 03/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2014
1	GelsolinIBA 03/2014
1	OsteopontinIBA 03/2014
1	Methotrexate (Mexate)FDA LinkGeneric 09/2013
1	Adalimumab (Humira)FDA Link 09/2013
1	Methionine Sulfoxide ReductasesIBA 10/2012
1	cyclic citrullinated peptideIBA 10/2012
1	Anti-Citrullinated Protein AntibodiesIBA 10/2012
1	CytokinesIBA 09/2012
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 02/2012
1	Cytokine Receptor gp130IBA 12/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2011
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 03/2009
1	Caspase 7IBA 08/2007
1	Aspartic Acid (Aspartate)FDA Link 01/2007
1	micaIBA 09/2006
1	Macrophage Migration-Inhibitory FactorsIBA 07/2006
1	UbiquitinIBA 06/2006
1	Core Binding Factor Alpha 2 SubunitIBA 06/2006
1	Codon (Codons)IBA 01/2006
1	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 09/2005
1	Interleukin-12 Subunit p40IBA 09/2005
1	Interleukin-12 (IL 12)IBA 09/2005
1	Interleukin-23 (Interleukin 23)IBA 09/2005
1	Interleukin-18 (Interleukin 18)IBA 06/2005
1	Interleukin-1 (Interleukin 1)IBA 06/2005
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 07/2004
1	Monoclonal AntibodiesIBA 02/2002
1	Complement System Proteins (Complement)IBA 01/2001
1	HLA-DRB1*04 antigenIBA 09/2000
1	Retinaldehyde (Retinal)IBA 05/2000
1	Chemokine CCL5IBA 05/2000
1	HLA-DR Antigens (HLA-DR)IBA 04/2000
1	Tuberculin (PPD)IBA 03/2000
1	Penicillamine (Cuprimine)FDA Link 01/2000

Therapy/Procedure

6	Therapeutics 01/2022 - 06/2012